文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

全球肺动脉高压与心力衰竭及射血分数保留或降低相关的血管重构。

Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction.

机构信息

Department of Cardiovascular Medicine (A.U.F., J.J.M., E.A.K., B.A.B., R.P.F., M.M.F.).

Department of Laboratory Medicine and Pathology (A.U.F., W.D.E., J.J.M.).

出版信息

Circulation. 2018 Apr 24;137(17):1796-1810. doi: 10.1161/CIRCULATIONAHA.117.031608. Epub 2017 Dec 15.


DOI:10.1161/CIRCULATIONAHA.117.031608
PMID:29246894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5915920/
Abstract

BACKGROUND: We hypothesized that pulmonary venous hypertension in heart failure (HF) leads to predominate remodeling of pulmonary veins and that the severity of venous remodeling is associated with the severity of pulmonary hypertension (PH) in HF. METHODS: Patients with HF (n=108; 53 preserved and 55 reduced ejection fraction) with PH (HF-PH; pulmonary artery systolic pressure [PASP] ≥40 mm Hg) were compared to normal controls (n=12) and patients with primary pulmonary veno-occlusive disease (PVOD; n=17). In lung specimens from autopsy (control, HF-PH, and 7 PVOD) or surgery (10 PVOD), quantitative histomorphometry was performed in all analyzable arteries (n=4949), veins (n=7630), and small indeterminate vessels (IV; n=2168) to define percent medial thickness (arteries) and percent intimal thickness (%IT) (arteries, veins, and IV) relative to external diameter. RESULTS: The average arterial percent medial thickness (control, 6.9; HF-PH, 11.0; PVOD, 15.0), arterial %IT (control, 4.9; HF-PH, 14.9; PVOD, 31.1), venous %IT (control, 14.0; HF-PH, 24.9; PVOD, 43.9), and IV %IT (control, 10.6; HF-PH, 25.8; PVOD, 50.0) in HF-PH were higher than controls (<0.0001 for all) but lower than PVOD (≤0.005 for all). PASP (mm Hg) was lower in HF-PH (median, 59 [interquartile range, 50-70]) than in PVOD (median, 91 [interquartile range, 82-103]). PASP correlated with arterial percent medial thickness (=0.41) and arterial %IT (=0.35) but more strongly with venous %IT (=0.49) and IV %IT (=0.55) (<0.0001 for all). Associations between PASP and venous or IV %IT remained significant after adjusting for arterial percent medial thickness and %IT and did not vary by HF type. In patients with right heart catheterization (30 HF-PH, 14 PVOD), similar associations between the transpulmonary gradient and pulmonary vascular remodeling existed, with numerically stronger associations for venous and IV %IT. Although the PASP was slightly higher in patients with HF-PH with right ventricular dysfunction, pulmonary vascular remodeling was not more severe. Pulmonary vascular remodeling severity was associated with reductions in the diffusing capacity of the lungs. CONCLUSIONS: In HF, PH is associated with global pulmonary vascular remodeling, but the severity of PH correlates most strongly with venous and small IV intimal thickening, similar to the pattern observed in PVOD. These findings expand our understanding of the pathobiology of PH in HF.

摘要

背景:我们假设心力衰竭(HF)中的肺静脉高压导致肺静脉的主要重塑,并且静脉重塑的严重程度与 HF 中的肺动脉高压(PH)的严重程度相关。

方法:将 108 例 PH(HF-PH;肺动脉收缩压[PASP]≥40mmHg)HF 患者(53 例射血分数保留和 55 例射血分数降低)与正常对照组(n=12)和原发性肺静脉阻塞性疾病(PVOD;n=17)患者进行比较。在尸检(对照组、HF-PH 和 7 例 PVOD)或手术(10 例 PVOD)肺标本中,对所有可分析的动脉(n=4949)、静脉(n=7630)和小不定型血管(IV;n=2168)进行定量组织形态计量学,以确定相对外部直径的中膜厚度百分比(动脉)和内膜厚度百分比(%IT)(动脉、静脉和 IV)。

结果:HF-PH 中的平均动脉中层厚度百分比(对照组,6.9;HF-PH,11.0;PVOD,15.0)、动脉%IT(对照组,4.9;HF-PH,14.9;PVOD,31.1)、静脉%IT(对照组,14.0;HF-PH,24.9;PVOD,43.9)和 IV%IT(对照组,10.6;HF-PH,25.8;PVOD,50.0)高于对照组(所有 P<0.0001),但低于 PVOD(所有 P≤0.005)。HF-PH 中的 PASP(mmHg)(中位数,59[四分位距,50-70])低于 PVOD(中位数,91[四分位距,82-103])。PASP 与动脉中层厚度百分比(r=0.41)和动脉%IT(r=0.35)相关,但与静脉%IT(r=0.49)和 IV%IT(r=0.55)相关性更强(所有 P<0.0001)。在调整了动脉中层厚度百分比和%IT 后,PASP 与静脉或 IV%IT 之间的相关性仍然显著,并且与 HF 类型无关。在接受右心导管检查的患者(30 例 HF-PH,14 例 PVOD)中,也存在跨肺梯度与肺血管重塑之间的类似关联,静脉和 IV%IT 的关联更为明显。尽管 HF-PH 合并右心室功能障碍患者的 PASP 略高,但肺血管重塑并不更严重。肺血管重塑的严重程度与肺弥散能力的降低有关。

结论:在 HF 中,PH 与肺血管的整体重塑相关,但 PH 的严重程度与静脉和小 IV 内膜增厚最相关,这与 PVOD 中观察到的模式相似。这些发现扩展了我们对 HF 中 PH 的病理生物学的理解。

相似文献

[1]
Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction.

Circulation. 2017-12-15

[2]
RV Contractile Function and its Coupling to Pulmonary Circulation in Heart Failure With Preserved Ejection Fraction: Stratification of Clinical Phenotypes and Outcomes.

JACC Cardiovasc Imaging. 2017-4-12

[3]
Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.

Circ Heart Fail. 2016-6

[4]
Echocardiographic assessment of pulmonary artery systolic pressure and outcomes in ambulatory heart failure patients.

J Am Heart Assoc. 2014-2-3

[5]
Clinical and echocardiographic correlates of pulmonary hypertension among heart failure patients in Lagos, south-western Nigeria.

Cardiovasc J Afr. 2019

[6]
Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.

Eur J Heart Fail. 2017-6-8

[7]
Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure.

Circ Heart Fail. 2017-9

[8]
Assessment of right ventricular function in advanced heart failure with nonischemic dilated cardiomyopathy: insights of right ventricular elastance.

J Cardiovasc Med (Hagerstown). 2020-2

[9]
Usefulness of Right Ventricular to Pulmonary Circulation Coupling as an Indicator of Risk for Recurrent Admissions in Heart Failure With Preserved Ejection Fraction.

Am J Cardiol. 2019-5-25

[10]
Pulmonary vascular mechanical consequences of ischemic heart failure and implications for right ventricular function.

Am J Physiol Heart Circ Physiol. 2019-5-1

引用本文的文献

[1]
Evaluation of pulmonary hypertension in heart failure with preserved ejection fraction.

Heart Fail Rev. 2025-9-9

[2]
Pharmacological inhibition of IL12β is effective in treating pressure overload-induced cardiac inflammation and heart failure.

Front Immunol. 2025-8-15

[3]
Small vessels, big problem: a dive into the pulmonary microcirculation in pulmonary hypertension and methods for evaluation.

EBioMedicine. 2025-7-25

[4]
Hemodynamic Definitions, Phenotypes, Pathophysiology, and Evaluation of Pulmonary Hypertension Related to Left Heart Disease.

J Cardiovasc Dev Dis. 2025-6-22

[5]
Bioinformatics Analysis Identifies a Potential Key Gene in the Pathogenesis of Pulmonary Hypertension-HSPH1.

Pulm Circ. 2025-7-16

[6]
Physiologic Phenotyping of Responses to Exercise and Activity in Heart Failure.

Circ Res. 2025-7-7

[7]
Long-Term Outcomes of Mitral Valve Repair With Artificial Chordae and Annuloplasty for Myxomatous Mitral Valve Disease in Dogs.

J Vet Intern Med. 2025

[8]
The nitrofen/bisdiamine murine model of congenital diaphragmatic hernia has a pulmonary hypertension vascular phenotype consistent with human CDH.

Am J Physiol Lung Cell Mol Physiol. 2025-7-1

[9]
Therapeutic challenges and new therapeutic targets for combined capillary pulmonary hypertension: a review.

Front Med (Lausanne). 2025-5-2

[10]
Right Ventricular-Pulmonary Artery Uncoupling and Strain in Acute Heart Failure.

J Am Heart Assoc. 2025-5-6

本文引用的文献

[1]
What can we learn from pulmonary function testing in heart failure?

Eur J Heart Fail. 2017-8-14

[2]
Pulmonary vascular remodeling in pulmonary hypertension.

Cell Tissue Res. 2017-3

[3]
Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum.

J Am Coll Cardiol. 2016-7-26

[4]
Impaired Pulmonary Diffusion in Heart Failure With Preserved Ejection Fraction.

JACC Heart Fail. 2016-6

[5]
Pulmonary veno-occlusive disease.

Eur Respir J. 2016-3-23

[6]
Diffusion Capacity and Mortality in Patients With Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction.

JACC Heart Fail. 2016-2-10

[7]
Lung congestion in chronic heart failure: haemodynamic, clinical, and prognostic implications.

Eur J Heart Fail. 2015-10-14

[8]
Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial.

Eur Heart J. 2015-7-17

[9]
Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension.

Circulation. 2015-6-9

[10]
Pulmonary hypertension caused by pulmonary venous hypertension.

Pulm Circ. 2014-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索